1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021 May;71(3):209-49. [
DOI:10.3322/caac.21660] [
PMID]
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: source, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):359-86. [
DOI:10.1002/ijc.29210] [
PMID]
3. Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, et al. ICO information Centre on HPV and Cancer (HPV information centre) human papillomavirus and related diseases reports [cited Mar 20 2015]. Available from: http://www.hpvcentre.net/statistics/reports/XWX.pdf. [
URL]
4. Shanmugham D, Vijay A, Rangaswamy T. Colposcopic evaluation of patient with persistent inflammatory pap smear. Sch J App Med Sci 2014;2:1010-3. [
URL]
5. Umarani MK, Gayathri MN, Kumar RM. Study of cervical cytology in Papanicolaou (Pap) smears in a tirtiary care hospital. Indian J Pathol Oncol. 2016;3;11:679-83. [
DOI:10.5958/2394-6792.2016.00126.5]
6. Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in Papanicolaou smears. J Cytol 2012;29(1):45-7. [
DOI:10.4103/0970-9371.93222] [
PMID] [
PMCID]
7. Ansari M, Mehdi G, Arif SH, Ansari H, Khan T. Smear patterns and spectrum of premalignant lesions in postmenopausal Indian women: A hospital based study. Diagn Cytopathpathol 2012;40:976-83. [
DOI:10.1002/dc.21708] [
PMID]
8. Thomas A, Corrara MMA, Kumar KR. The Bathesda system recommendation in reporting benign endometrial cells in cervical smears from postmenopausal women published by American Cancer Society. Indian J Pathol Microbiol 2002;25:134-8.
9. Ngoma T. World Health Organization cancer priorities in developing countries. Ann Oncol 2006;17:9-14. [
DOI:10.1093/annonc/mdl982] [
PMID]
10. Vaghela BK, Vaghela VK, Santwani PM. Analysis of abnormal cervical cytology in papanicolaou smears at tertiary care center-A retrospective study. Int J of Biomed Adv Res 2014;5:47-9. [
DOI:10.7439/ijbar.v5i1.551]
11. Aswathy S, Quereshi MA, Kurian B, Leelamoni K. Cervical cancer screening; Current knowledge and practice among women in a rural population of Kerala, India. Indian J Med Res 2012;136(2):205-10. [
PMID] [
PMCID]
12. Davey DD. Cervical cytology classification and the Bethesda System. Cancer J 2003;9(5):327-34. [
DOI:10.1097/00130404-200309000-00002] [
PMID]
13. Nayir T, Okyay AR, Nizlican E, Yesilyurt H, Akbaba M, Ilhan B, et al. Cervicalcancer screening in an early diagnosis and screening centre in Mersin, Turkey. Asian Pac J Cancer Prev 2015;16:690-12. [
DOI:10.7314/APJCP.2015.16.16.6909] [
PMID]
14. Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health 2015;7:405-14. [
DOI:10.2147/IJWH.S50001] [
PMID] [
PMCID]
15. Sunita A, Bamanikar SA, Baravkar DS. chandanwale SS, Dapkekar P. Study of cervical pap smears in a tertiary hospital. Int J Sci Res 2016;5(5):2071-4. [
DOI:10.21275/v5i5.NOV163871]